Literature DB >> 8376791

Functional and phenotypic analysis of thymocytes in SCID mice. Evidence for functional response transitions before and after the SCID arrest point.

E V Rothenberg1, D Chen, R A Diamond.   

Abstract

Thymocytes from severe combined immune deficient (SCID) mice undergo developmental arrest at an early stage, before most TCR gene rearrangement. They therefore represent a natural test case to assess those aspects of T cell development that are TCR independent. Multiparameter flow cytometry was used to analyze the array of immature phenotypes present in the SCID thymus at steady state, as defined by the markers CD4, CD5, Sca-1, NK1.1, CD44, heat-stable antigen (HSA), and IL-2R alpha. The results suggest a simple developmental block in SCID mice rather than a program of aberrant differentiation. SCID thymocytes displayed efficient, developmentally regulated functional responses. Approximately 20-25% of the cells, mostly within the IL-2R alpha +HSA+CD44low fraction, could be induced to express IL-2. This IL-2 inducibility was highly dependent on IL-1 costimulation, in agreement with the behavior of normal immature thymocytes. These results formally demonstrate that competence to express IL-2 is developed independently of TCR expression or gene rearrangement. Comparison of the response properties of various SCID thymocyte subsets indicated that IL-2 inducibility is first likely to be acquired at an early (Sca-1++CD44++HSAlow) stage. A later functional transition was revealed by comparing patterns of IL-2R alpha regulation in normal and SCID IL-2R alpha +HSA+CD44low thymocytes. The SCID thymocytes uniformly maintained IL-2R alpha expression on in vitro stimulation, whereas only a minority of the normal cells in the corresponding subset could do so unless IL-1 was also added. The SCID arrest point thus appears to separate the IL-2R alpha +HSA+CD44low stage into distinct early (TCR independent) and late phases. Normal cells that progress beyond the SCID arrest point appear to lose, rather than gain, competence to make various responses, even before they leave the IL-2R alpha +HSA+CD44low stage. A model is proposed in which discrete changes in functional competence define novel transitions in early thymocyte development, at least some of which may be linked to TCR-beta gene rearrangement before positive or negative selection.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8376791

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  Interferons alpha/beta inhibit IL-7-induced proliferation of CD4- CD8- CD3- CD44+ CD25+ thymocytes, but do not inhibit that of CD4- CD8- CD3- CD44- CD25- thymocytes.

Authors:  D M Su; J Wang; Q Lin; M D Cooper; T Watanabe
Journal:  Immunology       Date:  1997-04       Impact factor: 7.397

2.  An overview of IL-7 biology and its use in immunotherapy.

Authors:  Nahed ElKassar; Ronald E Gress
Journal:  J Immunotoxicol       Date:  2010-03       Impact factor: 3.000

3.  Cross-lineage expression of Ig-beta (B29) in thymocytes: positive and negative gene regulation to establish T cell identity.

Authors:  H Wang; R A Diamond; E V Rothenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-09       Impact factor: 11.205

Review 4.  A dynamic assembly of diverse transcription factors integrates activation and cell-type information for interleukin 2 gene regulation.

Authors:  E V Rothenberg; S B Ward
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

5.  Morphologic and Immunohistochemical Characterization of Spontaneous Lymphoma/Leukemia in NSG Mice.

Authors:  Heather Tillman; Laura J Janke; Amy Funk; Peter Vogel; Jerold E Rehg
Journal:  Vet Pathol       Date:  2019-11-18       Impact factor: 2.221

6.  Cell-type-specific epigenetic marking of the IL2 gene at a distal cis-regulatory region in competent, nontranscribing T-cells.

Authors:  Satoko Adachi; Ellen V Rothenberg
Journal:  Nucleic Acids Res       Date:  2005-06-03       Impact factor: 16.971

7.  The GTPase rho controls a p53-dependent survival checkpoint during thymopoiesis.

Authors:  P S Costello; S C Cleverley; R Galandrini; S W Henning; D A Cantrell
Journal:  J Exp Med       Date:  2000-07-03       Impact factor: 14.307

8.  Extracellular signal-regulated kinase (ERK) activation by the pre-T cell receptor in developing thymocytes in vivo.

Authors:  A M Michie; S Trop; D L Wiest; J C Zúñiga-Pflücker
Journal:  J Exp Med       Date:  1999-12-06       Impact factor: 14.307

9.  Altered T cell development in mice with a targeted mutation of the CD3-epsilon gene.

Authors:  M Malissen; A Gillet; L Ardouin; G Bouvier; J Trucy; P Ferrier; E Vivier; B Malissen
Journal:  EMBO J       Date:  1995-10-02       Impact factor: 11.598

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.